We previously have characterized a cluster of genes encoding cathepsin G (CG) and two other CG-like hematopoietic serine proteases, CGL-1 and CGL-2, on human chromosome 14. In this report, we clone and characterize a novel, related murine hematopoietic serine protease gene using human CG (hCG) cDNA as the probe. This murine gene spans -2.5 kb of genomic DNA, is organized into five exons and four introns, and bears a high degree of homology to hCG at both nucleic acid (73%) and deduced amino acid (66%) levels. The predicted cDNA contains an open reading frame of 783 nucleotides that encodes a nascent protein of 261 amino acids. Processing of a putative signal (pre)
fourth, related serine protease gene for human mast cell chymase also maps to chromosome 143 and has recently been shown to lie 50 to 150 kb downstream from the hCG gene? These human genes represent recent additions to a large, highly related hematopoietic serine protease gene family whose members have been characterized most extensively in rodents. The organization, homology, and linkage of members of this gene family suggest evolution from a common ancestral however, the expression of individual genes is segregated within distinct hematopoietic lineages and is strictly regulated at specific stages of development. hCG is a myelomonocytic lineage-specific protease packaged in the azurophil granules of neutrophils and chymase is found in the secretory granules of the MCTc subset of human mast cells.10311 CGL-1 and CGL-2 are granule-associated proteases of activated cytotoxic lymphocyte^.^^'^.^^ Expression of hCG transcripts has been directly demonstrated only in myelomonocytic precursors,14 although recent evidence suggests that hCG may be expressed peripherally in mast cells as CGL-1 was first characterized as 0 1993 by The American Society of Hematology.
cDNA clones 1-3E16 and HSE26.1," which were obtained from staphylococcal enterotoxin A-stimulated, or allogeneically stimulated, interleukin-2 (IL-2)-expanded peripheral blood leukocytes, respectively. The genomic structure of CGL-1 is identical to that reported for hCTLA-1 , I 8 SECT,I9 and CSP-B2'; its murine counterpart is designated CCP-1 or granzyme B.23 This gene is not expressed in quiescent lymphocytes, but is transcriptionally activated in T cells treated with a variety of agents, including those that stimulate the T-cell receptor.24 CGL-2 is also known as h-CCPX,2S or human granzyme H. 13 A cDNA for this gene (designated CSP-C) and for the rat orthologue (RNKP-I) have been de~c r i b e d ,~~,~' but no murine orthologue has been clearly identified. Although expression of this gene has not been convincingly demonstrated in T cells, both CGL-l/CSP-B and CGL-2/h-CCPX transcripts are detected in peripheral blood lymphocytes activated with IL-2 (lymphokine-activated killer [LAK] cells) and in natural killer (NK) cells, which comprise a majority of the LAK population.2,20,2' Thus, CGL-2 expression may be restricted to the NK population of cytotoxic lymphocytes.2 The rat orthologue for granzyme B was originally cloned from the NK cell line RNK-lb and was designated rat NK protease-1 (RNKP-1).27 At least seven different hematopoietic serine proteases (granzymes A through G) have been identified from murine cytotoxic lymphocytes.* Four of these, CCPl through 4 (granzymes B, C, E, and F), have been mapped to the CTLA-1 locus on murine chromosome 14, and are syntenic with the murine T-cell receptor a-chain locus, TcraZ9 Additionally, at least six murine mast cell serine proteases, designated MMCP-1 through 6, have been identified. 30 Although the genes that encode these hematopoietic serine proteases all are related to those in the human cluster, none is clearly more related to the hCG gene than any other. However, a CG-like protease has been purified from the mouse myeloid leukemia line, M 131; the N-terminal amino acid sequence for this serine protease and for rat polymorphonuclear leu-kocyte CG have been recently p~b l i s h e d .~~,~~ In this report, we identify a mouse genomic fragment that strongly hybridizes with an hCG cDNA probe, and characterize an -2.5-kb serine protease gene contained within. The genomic organization, nucleic acid and deduced amino acid sequences, chromosomal localization, and pattern of expression of this gene provide convincing evidence that it is the orthologue of the hCG gene.
MATERIALS AND METHODS

Molecular cloning of murine CG (mCG).
A murine fibroblast genomic library constructed in A-fix (Stratagene, La Jolla, CA) was screened as described.34 A 0.75-kb EcoRI-Hind111 fragment of the hCG cDNA9 was random primer-labeled with [a-"PIdATP (Bethesda Research Laboratories kit; Bethesda Research Laboratories, Gaithersburg, MD) for use as a hybridization probe, as described previou~ly.'~ One clone, designated AmCG6, contained EcoRI (6.7 kb) and HindIII (3.7 kb) fragments that were subcloned into pUC9 for further analyses, yielding plasmids designated pmCGe6.7 and pmCGh3.7, respectively.
The pmCGh3.7 and derivative plasmids were sequenced on both strands using the method of Sanger with cloned T7 DNA polymerase (Sequenase 2.0; US Biochemical Corp, Cleveland, OH). Sequence analyses were performed using Beckman MicroGenie software (version 6.0).
Chromosomal localization by interspecific backcross mapping. Interspecific backcross progeny were generated by matings of [(C57BL/6J X Mus spretus)FI X C57BL/6J] mice. This interspecific backcross mapping panel has been typed for more than 850 loci that are well distributed among all the autosomes, as well as for the X c h r o m~s o m e .~~ A total of 205 N2 progeny were obtained; a random subset of these N2 mice were used to map the CG (Ctsg) locus (see Results for details). DNA isolation, restriction enzyme digestion, agarose gel electrophoresis, and Southern blot transfer and hybridization were performed essentially as described?' To map the Cfsg locus, a 0.8-kb Bgl I1 fragment of mCG genomic DNA (containing the first exon and intron) was used as the probe. Zetabind nylon membrane blots (AMF-Cuno) were washed at a final stringency of 0.5X SSCP, 0.1% sodium dodecyl sulfate (SDS) at 65°C. In HindIII digests of C57BL/6J and Mus spretus DNA, this probe detects fragments of 3.8 and 2.5 kb, and 3.2, 2.0, and 0.5 kb, respectively. The three Mus sprefus-specific fragments cosegregated in backcross mice and were used to determine the murine chromosomal location of Cfsg. A description of the probes and restriction fragment length polymorphisms (REPS) for the cytotoxic T-lymphocyte antigen-1 (Cfla-I), T-cell receptor a-chain (Tcra), and connexin-26 (Cxn-26) loci has been reported p r e v i o u~l y .~~.~~ Recombination distances were calculated as described@ using the computer program SPRETUS MADNESS. Gene order was determined by minimizing the number of recombination events required to explain the allele distribution patterns.
Total cellular RNA was prepared from a panel of organs and tissues of normal C57BL/6J X C3H hybrid mice using a guanidinium thiocyanate miniprep as described!' Preparation of y-'*P-end-labeled probes and S 1 nuclease protection assays were performed as previously described!2 The murine p2-microglobulin (mp2M) probe is a genomic fragment labeled at the BamHI site in exon 2. Two specific (non-cross-hybridizing) mCG probes were generated for S1 protection assays: (1) an exon 4 probe labeled at a Bgl I1 site (used for tissue survey analysis and described in detail in Fig 5) ; and (2) an exon 1 probe labeled at a Sty I site located 38 bp from the predicted translation initiation site (used to define the transcription initiation site). Autoradiograms were exposed for 24 to 72 hours at -70°C.
DNA sequencing and analyses.
RNA preparation and analysis.
In situ RNA hybridization. Bone marrow obtained from normal adult C57BL/6J X C3H hybrid mice was washed, pelleted, and resuspended in chilled (4°C) 1X 
RESULTS
Sequence analysis of XmCG6 shows a serine protease gene with strong homology to hCG. The hCG cDNA probe used to identify the genomic hCG gene35 was used to screen 5.0 X lo5 plaques from a murine genomic library. Under high stringency, one phage clone, designated XmCG6, was purified to homogeneity and amplified for DNA preparation. Southem analysis with the same probe identified strongly hybridizing EcoRI (6.7 kb) and HindIII (3.7 kb) fragments of XmCG6 (data not shown). These fragments, and smaller Bgl I1 subfragments, were subcloned into pUC vectors and sequenced on both strands. As shown in Fig 1, the five exonfour intron genomic structure of a hematopoietic serine protease gene is contained within -3.5 kb of XmCG6 DNA, as deduced by comparison with hCG and other hematopoietic serine protease genes. The first exon is 83 bp long, including a short 28-nt 5' untranslated region (as measured by S1 nuclease protection, see below) that begins 30 bp downstream from a variant TATAA box motif, TAAAA, at position 4 17 (relative position -29). A single, in-frame consensus ATG translation initiation is found at position 475. Exons 2 through 5 are 148 bp, 136 bp, 255 bp, and 202 bp, respectively, excluding a 3' untranslated region of -90 bp as predicted from the atypical polyadenylation signal, ATTAAA,44 at position 3000. The first intron is the largest (633 bp), with second, third, and fourth intron lengths of 487 bp, 176 bp, and 392 bp, respectively. All introns conform to the GT/AG rule for splicing; the resulting splice phases of I, 11, 0, and 0 are strictly conserved among the members of this group of genes.
The intergenic relatedness that exists between the serine protease gene contained in XmCG6 (hereafter, mCG) and hCG is depicted in Fig 2. This dot matrix analysis was performed requiring a minimum match of 20 bp with 16 bp of identity, after alignment of the two genes with respect to transcriptional start sites; the analysis extends from the relative position -450 through the polyadenylation signal. The overall structural similarity between these two genes is apparent due to highly conserved exonic sequences. Striking homology also is found outside coding sequences in the 5' 
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For personal use only. on November 11, 2017. by guest www.bloodjournal.org flanking and 5' untranslated regions, and in the first and third introns. From transcriptional start to polyadenylation sites (-2.5 kb), these genes are 60.1% identical.
The 5' end of mCG messenger RNA (mRNA) was defined by an SI nuclease protection assay using bone marrow-derived RNA (see below) and a genomic DNA probe labeled at a Sfy I site near the end of exon I (Fig 1, position 5 13) . The protected band from this probe was compared with a sequencing ladder generated from an antisense primer that anneals at the end of exon 1. The size of the protected probe fragment (67 bp) indicates that the C at position 447 (Fig 1,  asterisk) is the most likely transcriptional start site for mCG (data not shown). The 13 bp surrounding this site, extending from position 443 through 45 1, are identical to those surrounding the transcriptional start site for hCG, which has a 5' untranslated region of identical length.3s
The immediate 5' flanking region contains consensus binding motifs for previously described transcription factors, as well as several islands of homology at conserved positions upstream from the hCG gene. The c-myb consensus sequence PyAACG/TG4547 is found at positions -408, -193, -139, + 1, and + 13 from the mCG transcriptional start site (the site at + 1 is conserved in hCG). The sequence from position + 13 to +20 (CAACGGTT) also conforms to a consensus binding sequence (PyAACPuGnT) of three myb-like motifs found upstream from the myb-responsive gene, mim-1 .4a An ets family consensus sequence of C/AGGAAG/T49,so occurs at positions -303 (a site conserved at a similar position [-3451 upstream from hCG) and at position -123. The sequence beginning at position -1 10 of mCG, TGATGAAACCTTT-CA, is identical to the 15-bp sequence beginning at position -1 14 of hCG. A pyrimidine tract beginning at position -59 of mCG (CCCTTCCTTCCTCTCTC) is also found at position -52 of hCG. Finally, the 11-bp sequence, GCAAACCTCCT, is found at positions -134 and -I38 of mCG and hCG, respectively. The significance of these conserved motifs is currently unknown.
mCG and hCG cDNA and amino acid sequences are highly conserved. tical) . This homology at the cDNA level translates to 66.4% identity between mCG and hCG amino acid sequences. An optimized alignment of the deduced, full-length proteins is shown in Fig 3. The two full-length serine proteases differ in length by only six residues (in exon 5). Like hCG, nascent mCG appears to be synthesized as a pre-proenzyme: a hydrophobic signal (pre) peptide of 18 amino acids is followed by a short, activation (pro) dipeptide, Gly-Lys. Processing and packaging of nascent mCG is predicted to generate a mature enzyme of 241 residues, beginning with an Ile-Ile motif at the amino terminus, as has been shown for hCG.9 The mature mCG protease has a calculated molecular mass of 26.898 Kd and an estimated PI of 11.99, which reflects the 35 basic residues.
The three residues that comprise the charge relay catalytic system of chymotrypsin (His57, AspLoz, and SerL9s)sL and all related serine proteases are conserved in mCG (His44, Asp88, and Serl8l). Note also the strict conservation of the residues flanking the catalytic triad and the conserved positions of all six cysteines. The position of a conserved, potential N-linked glycosylation site (Asn") is also shown. Finally, a seven amino acid hCG peptide that has broad spectrum antibacterial activity in vitroSZ is indicated beginning with His77. Four of the seven residues are conserved in the corresponding mCG sequence, including His-1 and Tyr-4, the two residues shown to be absolutely required for this activity.
The chromosomal locus for the mCG gene (Ctsg) maps to a cluster of serine protease genes on chromosome 14. The gene for hCG is found within a tightly linked cluster of hematopoietic serine protease genes on human chromosome 14, band q11.2.'v2 A similar serine protease gene cluster containing mCCP 1-4 has been mapped to murine chromosome 14 at the CTLA-1 locus.29 The murine chromosomal location for CG (Ctsg) was determined by interspecific backcross analysis. Our mapping results indicate that Cfsg is located on chromosome 14, tightly linked to the Tcra, Ctla-I, and Cxn-26 loci. A segregation analysis in which 185 mice were analyzed for each of these markers is shown in Fig 4; up to 197 mice were typed for some pairs of loci. The ratios of the total number of mice exhibiting recombinant chromosomes to the total number of mice analyzed for each pair of loci, Spaces separate the 18 amino acid signal (pre) peptide and the activation (pro) dipeptide from the mature protein, which begins with IleIle-Gly-Glv, initiating the numbering scheme for both proteins, as shown at the right. The positions of six conserved cysteine residues (*) and a conserved N-linked glycosylation site (*) are indicated. A seven amino acid peptide from hCG that has broad spectrum antimicrobial activity is underlined (His77 through Argn3). The residues forming the catalytic site (Hisu, Asp", and Ser'8') are shown in bold capital letters. The primary substrate binding site amino acids at position 175 are doubly underlined. No recombinants between Cth-1 and Ctsg were observed in 186 mice typed in common, suggesting that the two loci are within 1.6 cM of each other (upper 95% confidence limit); hCG and CGL-1 are -60 kb apart on human chromosome 14.192 Expression of mCG in the adult mouse is restricted to a small population of early myeloid cells in the bone marrow. The hCG gene is normally expressed only in promyelocytic/promonocytic cells.'4 We wished to determine the pattern of mCG gene expression in a survey of adult mouse organs and tissues using a specific S1 nuclease protection assay. Figure 5 is a representative analysis in which unique probes for mCG (depicted in the lower panel) and mpzM were simultaneously hybridized with total cellular RNA from the indicated organs and tissues (upper panel). Correctly spliced mCG mRNA should protect an exon-4 probe fragment of 2 12 nt from S 1 digestion; this mCG-specific band is detected only in bone marrow RNA (lane 4). Although the signal for mP2M-specific mRNA varies (in part from differential tissue expression), RNA from all other sources was consistently negative for mCG expression (at least 6 experiments).
Next, we wished to determine the cell type@) in the bone marrow responsible for the relatively high level of mCG expression by means of in situ RNA hybridization. mCG sense or antisense 35S-labeled cRNA probes were hybridized to murine bone marrow cytospin preparations. After washing and autoradiography (14 days of exposure), slides were counterstained and examined with bright-field microscopy. Figure  6 is a photomicrograph of a slide hybridized with antisense strand probe. The solid arrow indicates a positive cell displaying a morphology typical of that observed in at least 20 different antisense-hybridized slides from three separate experiments. These moderately large, mononuclear cells with a large nuclear-to-cytoplasmic ratio comprise from 0.8% to 1.5% of total cells and are consistent in both morphology and number with early myeloid-lineage cells. Later myeloidand lymphoid-lineage cells (open arrow), as well as megakaryocytes and erythroid-lineage cells, did not hybridize with the mCG probe. N o hybridization above background levels was observed on slides incubated with the sense strand mCG probe (data not shown). A subset of developed slides was stained for the presence of myeloid-specific chloroacetate esterase before counterstaining. Most of the mCG-positive cells also had detectable chloroacetate esterase activity, although the extensive processing of these slides depletes much of this activity (data not shown).
DISCUSSION
hCG is a well-characterized member of a large group of hematopoietic serine proteases whose functions are incom-1619 pletely understood. Using the cDNA for hCG as a probe, we have identified a 6.7-kb EcoRI restriction fragment from a murine genomic library that contains a gene encoding a novel serine protease, mCG. This gene shares extensive homology with its human orthologue at genomic, cDNA, and amino acid sequence levels. Consensus binding site motifs for myh and ets family transcription factors and 1 I-to 17-bp stretches of identity are conserved at similar positions in the immediate 5' flanking regions of both genes. Like hCG, mCG is situated within a cluster of highly related serine protease genes on chromosome 14. Like hCG, mCG is expressed at high level in the bone marrow, where mCG transcripts are detected in a small population of early myeloid cells.
The genomic structure of mCG conforms to a format common within the hematopoietic serine protease gene family: five exons and four introns with conserved splice phases, short 5' and 3' untranslated regions, and the physical separation of sequences encoding a signal peptide, as well as each For personal use only. on November 11, 2017. by guest www.bloodjournal.org From residue of the catalytic triad, in distinct exons. These characteristics reflect at least two mechanisms that are likely to have contributed to the evolution of this gene family: ( I ) exon shuffling, generating diversity; and (2) gene duplication, giving rise to a cluster of highly related gene^.^.^.?' The homology between mCG and selected members of the hematopoietic serine proteases is summarized in Table l , with reference to hCG as the closest evolutionary relative and bovine chymotrypsin as the achetypal. common ancestor. In both the cytotoxic lymphocyte-associated and the mast cellassociated groups, mCG shares greatest homology with the human serine proteases clustered on chromosome 14. The nearest rodent relative of mCG is the rat orthologue of human granzyme B/CSP-B, rat NK cell protease-I (RNKP-I, 52.3% identity) (see Table I for references). However, 24 of the 26 N-terminal amino acids of rat CG are identical to those predicted to begin at the N-terminus of mature mCG; the rat orthologue may be even more closely related than hCG. 33 Regardless, the pattern of homologies presented in Table I is consistent with the assertion that an ancestral gene for CG existed before the evolutionary divergence of primates and rodents.' Furthermore, the Ctsg locus is found at the same position on murine chromosome 14 as Ctla-1 (Fig 4) , a locus known to contain a cluster ofat least four other related murine hematopoietic serine protease genes that is syntenic with the T-cell receptor a-chain locus (Tcr~).~' Because there is a syntenic homology group for these loci on human chromosome 14. this suggests that tandem sequential gene duplication events occurred (involving the ancestral CG gene) before the primate-rodent split.
The overall structure of the deduced mCG protein is remarkably similar to that of hCG and many related serine proteases. yet there are several regions where a lack of conservation may provide important clues about the processing of nascent mCG and its substrate specificity. The N-termini for granule-purified hCG, CGL-2/CSP-B, and human chymase begin with the four residues, Ile'-Ile-Gly-Gly'~'2.'5; these four N-terminal residues are invariant in all of the deduced human and rodent granzymes and mast cell proteases. Thus, the corresponding residues in mCG (Fig 3) likely define the N-terminus after processing of the prepropeptide. As in all of these serine proteases (except for granzyme A/HuHF and MMCP-5), the prepropeptide consists of an 18 amino acid signal (pre) peptide and an activation (pro) dipeptide. Two residues of the prepropeptide of mCG, Asp'6 and LysZo, are unusual in that: ( I ) Asp" would violate the (-3,-I)-rule for Expressed as the number matching per length after optimized alignment.
acceptable cleavage sites of eucaryotic signal peptidase because charged residues at the -3 position are not all~wed'~; and (2) the activation dipeptide for the hematopoietic serine proteases is usually acidic, with a GluZo at this position. The only other protease in this family that violates these rules is human granzyme A (HuHF), which bears identical residues to mCG at both of these positions. This raises the possibility that the putative N-terminal dipeptidase that removes the propeptide from all of these granule-associated serine proteases has a broad substrate specificity, or that isoforms exist that uniquely recognize either acidic or basic prodipeptides.
The conservation of the N-linked glycosylation site (Asn") in exon 2 and of all six cysteines (Fig 3) suggests that these residues are important for proper targeting and folding of the mature enzymes. There is good evidence that processing of carbohydrate from high mannose to complex type occurs for hCG, because sensitivity to endoglycosidase H is lost after 4 hours in U937 cells.54 CG purified from human neutrophils and hCG extracted from the neutrophils of transgenic mice carrying the full-length hCG gene are both sensitive to Nglycanase digestion, indicating that glycosylation at this single site occurs in both species (Heusel and Ley, unpublished observations, 1991) . The importance of glycosylation at this site for the targeting of either mCG or hCG to primary azurophil granules is unknown. The six N-terminal half-cysteinyl residues are precisely conserved in all of the granzymes and mast cell proteases listed in Table 1 , and are also present in mCG, however, the disulfide bond that bridges the active site serine in bovine chymotrypsin ( C y~'~~-C y s~~~) is conserved only in granzyme A/HuHF. The loss of this disulfide bond may alter the substrate specificity for the hematopoietic serine proteases without adversely affecting catalytic activity, as suggested by the reduction of this disulfide bond in bovine trypsin." Other conserved residues that are likely to contribute to the substrate specificities for both enzymes include the Ser-T~p-Glyl~~ sequence, which in chymotrypsin (Ser-TrpGly2I6) forms hydrogen bonds with substrate at positions P1 and P3, and the PZbinding site Ile"." However, the primary binding site amino acids (position 176, Fig 3) differ: this residue is a Serin mCG (as in chymotrypsin), but is Ala in hCG, indicating a more hydrophobic substrate specificity for the human serine protease.
The cloning and characterization of mCG provide additional information about the evolution and distribution of hematopoietic serine proteases as well as valuable reagents for ongoing functional analyses. For example, we are currently testing the activities of the conserved myb and ets promoter elements in light of a recent report showing cooperation between these two elements in the transcriptional activation of the mim-1 gene, which is also expressed in promyel~cytes.'~ Additionally, hCG has broad spectrum antimicrobial and platelet agonist activities that are functionally distinct from its enzymatic a~t i v i t y . '~~~~~~~ The physiologic importance of these activities can now be investigated through the targeted disruption of the mCG gene via homologous recombination, a study that is currently underway. For personal use only. on November 11, 2017. by guest www.bloodjournal.org From
